Internal Server Error

Kardium - About the company

Kardium is a series C company based in Burnaby (Canada), founded in 2007 by Dan Gelbart, Ruslan Nikolaev, Amos Michelson and Sam Lichtenstein. It operates as a Developer of ablation device for atrial fibrillation. Kardium has raised $471M in funding from investors like Fidelity Investments, T. Rowe Price and Janus Henderson Investors. The company has 16 active competitors, including 10 funded and 3 that have exited. Its top competitors include companies like Galvanize, Field Medical and Argá Medtech.

Company Details

Kardium is developing the Globe mapping and ablation system. It's an investigational medical device, used in the diagnosis and treatment of atrial fibrillation. It provides mapping, stimulation, and RF ablation of cardiac tissue.
Social
XFacebook
Registered Address
2900 - 550 Burrard Street, Vancouver
Key Metrics
Founded Year
2007
Location
Burnaby, Canada
Stage
Series C
Total Funding
$471M in 6 rounds
Latest Funding Round
Ranked
Employee Count
578 as on Mar 31, 2026
Similar Companies
Sign up to download Kardium's company profile

Kardium's funding and investors

Kardium has raised a total funding of $471M over 6 rounds. Its first funding round was on Jul 22, 2010. Its latest funding round was a Series C round on Jul 08, 2025 for $*****. 7 investors participated in its latest round. Kardium has 12 institutional investors.

Here is the list of recent funding rounds of Kardium:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jul 08, 2025
3194643
Series C
9004556
4895736
3897802
4345164
Jun 11, 2024
6098545
Series B
3133321
4820959
7367303
Dec 30, 2020
6919715
Series B
4279135
8578325
lockAccess funding benchmarks and valuations. Sign up today!

Kardium's founders and board of directors

Founder? Claim Profile
The founders of Kardium are Dan Gelbart, Ruslan Nikolaev, Amos Michelson and Sam Lichtenstein.
Here are the details of Kardium's key team members:

Kardium's employee count trend

Kardium has 578 employees as of Mar 26. Here is Kardium's employee count trend over the years:
Employee count trend for Kardium
lockUncover Kardium's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Kardium's Competitors and alternates

Top competitors of Kardium include Galvanize, Field Medical and Argá Medtech. Here is the list of Top 10 competitors of Kardium, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Kardium
Kardium
2007, Burnaby (Canada), Series C
Developer of ablation device for atrial fibrillation
$471M
64/100
2nd
Logo for Galvanize
Galvanize
2020, San Carlos (United States), Series C
Developer of pulsed electric field systems for various medical indications
$210M
58/100
3rd
Logo for Field Medical
Field Medical
2022, Encinitas (United States), Series B
Developer of device for the treatment of heart arrhythmia conditions
$75M
56/100
4th
Logo for Argá Medtech
Argá Medtech
2020, Epalinges (Switzerland), Series B
Developer of medical devices for treating cardiac arrhythmias
$58.5M
55/100
5th
Logo for Pulse Biosciences
Pulse Biosciences
2014, Burlingame (United States), Acquired
Developer of a platform technology called Nano-Pulse Electro-Signaling
$8M
50/100
6th
Logo for EnChannel Medical
EnChannel Medical
2020, Ladera Ranch (United States), Series B
Developer of medical device for cardiac disorders
$110M
48/100
7th
Logo for Farapulse
Farapulse
2014, Menlo Park (United States), Series C
Advanced cardiac ablation solutions for atrial fibrillation treatment
$36.3M
44/100
8th
Logo for Affera
Affera
2014, Boston (United States), Acquired
Developer of devices to treat heart rhythm disorders
-
43/100
9th
Logo for AtriAN
AtriAN
2017, Galway (Ireland), Seed
Developing the device that targets to atrial fibrillation
$2.56M
41/100
10th
Logo for JJET
JJET
1991, Chengdu (China), Series B
R&D company focused on producing and supplying of medical devices
$103M
32/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Kardium's competitors? Click here to see the top ones

Kardium's Investments and acquisitions

Kardium has made no investments or acquisitions yet.

News related to Kardium

lockFilter this list
Media has covered Kardium for a total of 11 events in the last 1 year, 6 of them have been about company updates.
Kardium Reports Strong PFA System Trial ResultsClinical Trials ArenaApr 28, 2025Kardium
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Kardium

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford